Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) EPS (Basic) (2016 - 2018)

Armata Pharmaceuticals' EPS (Basic) history spans 6 years, with the latest figure at -$0.24 for Q4 2018.

  • For Q4 2018, EPS (Basic) fell 119.51% year-over-year to -$0.24; the TTM value through Dec 2018 reached -$0.77, up 61.69%, while the annual FY2024 figure was -$0.52, 72.77% up from the prior year.
  • EPS (Basic) for Q4 2018 was -$0.24 at Armata Pharmaceuticals, down from -$0.1 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $3.69 in Q2 2014 and bottomed at -$8.22 in Q1 2016.
  • The 5-year median for EPS (Basic) is -$0.24 (2018), against an average of -$0.93.
  • The largest YoY upside for EPS (Basic) was 2150.0% in 2014 against a maximum downside of 10500.0% in 2014.
  • A 5-year view of EPS (Basic) shows it stood at -$0.16 in 2014, then crashed by 87.5% to -$0.3 in 2015, then crashed by 133.33% to -$0.7 in 2016, then surged by 275.71% to $1.23 in 2017, then crashed by 119.51% to -$0.24 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's EPS (Basic) are -$0.24 (Q4 2018), -$0.1 (Q3 2018), and -$0.19 (Q2 2018).